Jha T[Author] - Search Results

Year	Number of Results
1983	2
1984	1
1986	2
1987	1
1989	4
1990	2
1991	2
1992	2
1993	1
1994	1
1995	3
1996	3
1998	3
1999	1
2001	1
2002	6
2003	8
2004	7
2005	3
2006	4
2007	4
2008	2
2009	4
2010	7
2011	4
2012	4
2013	8
2014	11
2015	12
2016	6
2017	18
2018	18
2019	17
2020	21
2021	7

1

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.

Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Mondal S, et al. Among authors: jha t. Eur J Med Chem. 2020 May 15;194:112260. doi: 10.1016/j.ejmech.2020.112260. Epub 2020 Mar 21. Eur J Med Chem. 2020. PMID: 32224379 Review.

2

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.

Sarkar R, Banerjee S, Amin SA, Adhikari N, Jha T. Sarkar R, et al. Among authors: jha t. Eur J Med Chem. 2020 Apr 15;192:112171. doi: 10.1016/j.ejmech.2020.112171. Epub 2020 Feb 26. Eur J Med Chem. 2020. PMID: 32163814 Review.

3

meso-Thiophenium Porphyrins and Their Zn(II) Complexes: A New Category of Cationic Photosensitizers.

Mazumdar ZH, Sharma D, Mukherjee A, Basu S, Shukla PK, Jha T, Sengupta D. Mazumdar ZH, et al. Among authors: jha t. ACS Med Chem Lett. 2020 Sep 10;11(10):2041-2047. doi: 10.1021/acsmedchemlett.0c00266. eCollection 2020 Oct 8. ACS Med Chem Lett. 2020. PMID: 33062190

4

Fight against novel coronavirus: A perspective of medicinal chemists.

Amin SA, Jha T. Amin SA, et al. Among authors: jha t. Eur J Med Chem. 2020 Sep 1;201:112559. doi: 10.1016/j.ejmech.2020.112559. Epub 2020 Jun 12. Eur J Med Chem. 2020. PMID: 32563814 Free PMC article. Review.

5

HDAC6 as privileged target in drug discovery: A perspective.

Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B. Pulya S, et al. Among authors: jha t. Pharmacol Res. 2021 Jan;163:105274. doi: 10.1016/j.phrs.2020.105274. Epub 2020 Nov 7. Pharmacol Res. 2021. PMID: 33171304 Review.

6

Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.

Amin SA, Adhikari N, Jha T. Amin SA, et al. Among authors: jha t. J Med Chem. 2018 Aug 9;61(15):6468-6490. doi: 10.1021/acs.jmedchem.7b00782. Epub 2018 Apr 16. J Med Chem. 2018. PMID: 29630364 Review.

7

Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-present.

Baidya SK, Amin SA, Jha T. Baidya SK, et al. Among authors: jha t. Eur J Med Chem. 2020 Nov 24:113044. doi: 10.1016/j.ejmech.2020.113044. Online ahead of print. Eur J Med Chem. 2020. PMID: 33279289 Review.

8

A Review on Camptothecin Analogs with Promising Cytotoxic Profile.

Amin SA, Adhikari N, Jha T, Gayen S. Amin SA, et al. Among authors: jha t. Anticancer Agents Med Chem. 2018;18(13):1796-1814. doi: 10.2174/1871520618666180327140956. Anticancer Agents Med Chem. 2018. PMID: 29589546 Review.

9

Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization.

Amin SA, Adhikari N, Gayen S, Jha T. Amin SA, et al. Among authors: jha t. Biomed Pharmacother. 2017 Nov;95:818-827. doi: 10.1016/j.biopha.2017.09.004. Epub 2017 Sep 10. Biomed Pharmacother. 2017. PMID: 28892793 Review.

10

Selective and nonselective HDAC8 inhibitors: a therapeutic patent review.

Adhikari N, Amin SA, Jha T. Adhikari N, et al. Among authors: jha t. Pharm Pat Anal. 2018 Nov;7(6):259-276. doi: 10.4155/ppa-2018-0019. Epub 2019 Jan 11. Pharm Pat Anal. 2018. PMID: 30632447 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results